Peptides Vietnam LogoPeptides Vietnam
TestingOct 2026

Do Peptides Show Up on Drug Tests? What Testing Covers

Do peptides show up on drug tests? Sport drug tests look for them: USADA's 2020 guide says peptide hormones and releasing factors are banned at all times under section S2.2 of the WADA Prohibited List, and labs have published urine tests for BPC-157 and growth hormone peptides. What standard workplace panels include could not be documented here. NIDA, the US National Institute on Drug Abuse, says any drug test looks only for the specific drugs it targets.

Short answer

Workplace or standard drug test?
A test finds only the drugs it targets (NIDA). This guide could not confirm which drugs standard workplace panels include.
Sport drug test?
Yes, peptides are targeted. USADA says BPC-157 is banned under S0 and peptide hormones under S2.2 of the WADA list.
How small an amount can labs find?
A 2023 BPC-157 urine test finds 0.01 to 0.11 ng/mL. A 2026 test for GHRH-type peptides finds 0.5 ng/mL or lower.

Sources: NIDA, Drug Testing; USADA, 6 Things to Know About Peptide Hormones; USADA, BPC-157; Molecules 2023 (PMID 37959764); J Pharm Biomed Anal 2026 (PMID 41138283)

Which peptides have a published test?

Published detection data exist for BPC-157, the growth hormone releasing peptides and GHRH analogs, while TB-500 has horse data only and GHK-Cu has none, according to the records named in each row below.

Sport status, detection method or window, and species for each peptide or class, with the USADA page and journal paper named in each row. TB-500 data come from a horse study.
PeptideSport statusDetection method or window as reportedSpeciesRecord
BPC-157Banned under S0, Non-Approved SubstancesValidated urine method (UHPLC-HRMS, per the paper title) for BPC-157 and five breakdown products; detection limits 0.01 to 0.11 ng/mL. No detection window reportedHuman urineUSADA BPC-157 page (2022); Molecules 2023, PMID 37959764
GHRP-2, ipamorelin and other GHRPsPeptide hormones and releasing factors banned at all times under S2.2; single GHRPs not namedBreakdown products measured in urine after a nasal dose; GHRP-2 found up to 47 hHuman, one volunteer per peptideUSADA peptide hormones page (2020); Drug Test Anal 2015, PMID 25869809
GHRH and its analogsSermorelin banned for raising the body's own growth hormone (USADA)Nano liquid chromatography with mass spectrometry (per the paper title); detection limits 0.5 ng/mL or lowerUrine; species not stated in the quote used hereUSADA sermorelin page (2023); J Pharm Biomed Anal 2026, PMID 41138283
TB-500Not named in the USADA pages reviewedLiquid chromatography with mass spectrometry (per the paper title); 0.01 ng/mL in urine, 0.02 ng/mL in plasmaHorse only (horse study)J Chromatogr A 2012 horse study, PMID 23084823
GHK-CuNo USADA or WADA source foundNo doping control method foundNoneNone found
Semaglutide, tirzepatideIncretin drugs not on the WADA list, per a 2026 reviewNot covered in this guide's sourcesNot applicableInt J Mol Sci 2026 review, PMID 42511463

Sources: USADA, 6 Things to Know About Peptide Hormones; USADA, BPC-157; USADA, Sermorelin; Molecules 2023 (PMID 37959764); Drug Test Anal 2015 (PMID 25869809); J Pharm Biomed Anal 2026 (PMID 41138283); J Chromatogr A 2012 (PMID 23084823); Int J Mol Sci 2026 (PMID 42511463)

What does a standard drug test look for?

A standard drug test looks only for a set list of drugs above a cutoff level, according to NIDA's drug testing page, so a peptide shows up only if the panel targets it. Whether peptides are on workplace or military panels could not be documented, because the official panel pages could not be retrieved. MedlinePlus, the US National Library of Medicine site, says a test looks for illegal drugs and for some prescription and store-bought medicines that people misuse.

When a result needs checking, NIDA says labs use mass spectrometry. That is a lab method that weighs molecules to name them. The peptide studies below use the same kind of method.

This guide could not confirm what a standard workplace or military panel includes. The official panel pages could not be retrieved. So this page does not say peptides are, or are not, on any named panel. The testing lab or employer can tell you what their panel covers.

Sources: MedlinePlus, Drug Testing; NIDA, Drug Testing

Are peptides banned in sport?

Peptides are banned in sport: USADA's 2020 page says peptide hormones and releasing factors are prohibited at all times under section S2.2 of the WADA Prohibited List, and its 2022 page says BPC-157 is prohibited under section S0. WADA is the World Anti-Doping Agency. The 2020 page adds that a drug not named on the list can still be banned if it has a similar structure or a similar effect.

Sport status of peptides, with the USADA page or review named in each row.
Peptide or ruleWhat the record saysRecord
Peptide hormones and releasing factorsBanned at all times, WADA list section S2.2USADA, 6 Things to Know About Peptide Hormones (2020)
BPC-157Banned under S0, Non-Approved Substances. Not approved for human use by the FDA or any health authorityUSADA, BPC-157 page (2022)
SermorelinBanned because it can boost muscle growth, endurance and recovery by raising the body’s own growth hormoneUSADA, sermorelin page (2023)
Peptide hormones in supplementsIllegal to sell in dietary supplementsUSADA (2020)
Semaglutide, tirzepatideIncretin drugs are not on the WADA list for nowInt J Mol Sci review (2026)

For the legal side in Vietnam, see peptide legality in Vietnam.

Sources: USADA, 6 Things to Know About Peptide Hormones; USADA, BPC-157; USADA, Sermorelin; Int J Mol Sci 2026 (PMID 42511463)

Can anti-doping labs detect peptides?

Anti-doping labs can detect several peptides in urine: a 2023 paper in Molecules (PMID 37959764) reports a BPC-157 urine test with detection limits of 0.01 to 0.11 ng/mL. That test also finds five of BPC-157's main breakdown products. A nanogram is a billionth of a gram.

A 2026 paper in the Journal of Pharmaceutical and Biomedical Analysis tested urine for GHRH, a growth hormone releasing hormone, and drugs like it. It found them at 0.5 ng/mL or lower. The authors called that sensitive enough to detect and confirm them.

The TB-500 data come from a horse study. In 2012, a doping lab found and confirmed TB-500 at 0.02 ng/mL in horse blood plasma. It found 0.01 ng/mL in horse urine. That shows the molecule can be found. It says nothing about how long it lasts in people.

Testing is still hard. A 2026 review says anti-doping groups have added new testing tools. But peptides look like the body's own hormones and leave the body fast, which makes them hard to catch.

Sources: Molecules 2023 (PMID 37959764); J Pharm Biomed Anal 2026 (PMID 41138283); J Chromatogr A 2012 (PMID 23084823); J Sports Med Phys Fitness 2026 (PMID 41880199)

How long do peptides stay detectable?

No human detection window is published for BPC-157, TB-500, CJC-1295 or GHK-Cu in these sources; the one human figure is for GHRP-2, found in urine up to 47 hours after a nasal dose (Drug Test Anal 2015, PMID 25869809). In that study, each peptide was given to one volunteer. Two GHRP-2 breakdown products were found for the same 47 hours.

The authors say the time depends on the person's body, the drug form and how it is taken. MedlinePlus says the same about drugs in general. It lists the drug, how much was used, how long it was used, and how the body reacts. For blood work, see peptide blood tests in Vietnam.

Sources: Drug Test Anal 2015 (PMID 25869809); MedlinePlus, Drug Testing

Common questions

Can GHK Cu show up on a drug test?+

No published test for GHK-Cu was found. This guide found no WADA, USADA or peer-reviewed doping control source on it. NIDA, the US National Institute on Drug Abuse, says drug tests look only for specific drugs above a set cutoff. So a test finds only what it is built to find.

Are peptides considered drugs?+

It depends on the peptide. USADA, the US Anti-Doping Agency, says BPC-157 is not approved for human use by the FDA or any other health authority. USADA also says it is illegal to sell peptide hormones in dietary supplements. In sport, its 2020 page says peptide hormones and releasing factors are banned at all times under section S2.2 of the WADA Prohibited List.

Is BPC-157 banned in sports?+

Yes. USADA's 2022 BPC-157 page says it is banned under S0, the Non-Approved Substances section of the WADA Prohibited List. A 2023 paper in the journal Molecules built and checked a way to find BPC-157 and five of its breakdown products in human urine.

Do peptides show up on a standard workplace drug test?+

This guide could not confirm what standard workplace or military panels include. The official panel pages could not be retrieved. What NIDA does say is that tests look only for specific drugs or drug groups above a cutoff. The testing lab or employer can tell you what their panel covers.

How long do peptides stay in your urine?+

There is no single number. In a 2015 study, each peptide was given by nasal spray to one volunteer. GHRP-2 and two of its breakdown products were found in urine up to 47 hours later. The authors say the time depends on the person, the drug form and how it is taken.

Is semaglutide or tirzepatide on the WADA banned list?+

A 2026 review says incretin drugs, the group that includes semaglutide and tirzepatide, are not on the WADA Prohibited List for now. Check the current list itself before relying on that.

Can TB-500 be detected?+

In horses, yes. A 2012 horse study found and confirmed TB-500 at 0.01 ng/mL in horse urine and 0.02 ng/mL in horse blood plasma. This guide found no human data on how long TB-500 can be detected.

Sources: NIDA, Drug Testing; USADA, 6 Things to Know About Peptide Hormones; USADA, BPC-157; Molecules 2023 (PMID 37959764); Drug Test Anal 2015 (PMID 25869809); J Chromatogr A 2012 (PMID 23084823); Int J Mol Sci 2026 (PMID 42511463)

Related reading

This guide is for education only and is not medical or legal advice. It describes what testing bodies and published studies report. It does not tell anyone how to pass or avoid a test.

Sources

  1. 1.MedlinePlus (US National Library of Medicine), Drug Testing, 2024, retrieved October 2026. Supports what a drug test looks for and what sets how long a drug stays in the body.
  2. 2.National Institute on Drug Abuse, Drug Testing, 2024, retrieved October 2026. Supports that tests target only specific drugs or classes above a cutoff, and confirmatory GC/MS or LC/MS testing.
  3. 3.US Anti-Doping Agency, 6 Things to Know About Peptide Hormones and Releasing Factors, 2020, retrieved October 2026. Supports the WADA S2.2 ban, the similar structure or effect rule, and that selling peptide hormones in supplements is illegal.
  4. 4.US Anti-Doping Agency, BPC-157: What Athletes Should Know About the Prohibited Experimental Peptide, 2022, retrieved October 2026. Supports the S0 listing and that BPC-157 is not approved for human clinical use.
  5. 5.US Anti-Doping Agency, What Should Athletes Know About Sermorelin?, 2023, retrieved October 2026. Supports why sermorelin is prohibited.
  6. 6.Stable isotope labeling-based nontargeted strategy for the in vitro metabolic profile of BPC-157 in doping control by UHPLC-HRMS. Molecules, 30 October 2023. PMID 37959764. Supports the validated human urine method and its 0.01 to 0.11 ng/mL detection limits.
  7. 7.Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. Drug Test Anal, October 2015. PMID 25869809. Supports one volunteer per compound, GHRP-2 detected up to 47 h, and what sets the window.
  8. 8.Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography with quadrupole/orbitrap mass spectrometry. J Pharm Biomed Anal, 15 January 2026. PMID 41138283. Supports detection limits of 0.5 ng/mL or lower.
  9. 9.Doping control analysis of TB-500, a synthetic version of an active region of thymosin beta-4, in equine urine and plasma by LC-MS. J Chromatogr A, 23 November 2012. PMID 23084823. Horse data: detection at 0.02 ng/mL in plasma and 0.01 ng/mL in urine.
  10. 10.A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review. J Sports Med Phys Fitness, July 2026. PMID 41880199. Supports the analytical challenges of peptide testing.
  11. 11.Incretin-based therapies in sports: pharmacological mechanisms, performance-enhancing potential, and anti-doping implications, a narrative review. Int J Mol Sci, 8 July 2026. PMID 42511463. Supports that incretin therapies are not on the WADA Prohibited List.